RU2011110910A - Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs) - Google Patents
Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs) Download PDFInfo
- Publication number
- RU2011110910A RU2011110910A RU2011110910/15A RU2011110910A RU2011110910A RU 2011110910 A RU2011110910 A RU 2011110910A RU 2011110910/15 A RU2011110910/15 A RU 2011110910/15A RU 2011110910 A RU2011110910 A RU 2011110910A RU 2011110910 A RU2011110910 A RU 2011110910A
- Authority
- RU
- Russia
- Prior art keywords
- prrs
- virus
- strain
- type
- pig
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
Abstract
1. Способ вакцинации свиньи от воздействия отличающейся высокой температурой формы PRRS, заключающийся в том, что вводят свинье иммуногенную композицию, содержащую в эффективном количестве вирус PRRS типа II. ! 2. Способ по п.1, в котором отличающаяся высокой температурой форма PRRS вызывается китайским штаммом PRRSV, который имеет нуклеотидную последовательность, гомологичную по меньшей мере на 95% нуклеотидной последовательности штамма НВ-1 или JX143. ! 3. Способ по п.1, в котором отличающаяся высокой температурой форма PRRS вызывается вирусом HP PRRS. ! 4. Способ по п.1, в котором вирус PRRS типа II является ослабленным. ! 5. Способ по п.3, отличающийся тем, что вирус PRRS типа II представляет собой ослабленную форму штамма, который имеет регистрационный № АТСС VR-2332, или его потомство. ! 6. Способ по п.4, отличающийся тем, что вирус PRRS типа II представляет собой штамм, который имеет регистрационный №АТСС VR-2495, или его потомство. ! 7. Способ по п.1, в котором китайский штамм PRRSV выбирают из группы, включающей АН-1; AHCFSH; AHCFZC; BB07; BD-8; BQ07; CL07; СХ07; CZ07; FY060915; FY080108; GC-2; GCH-3; GDI; GD2; GD2007; GD3; GD4; GDSD1; GDY1-2007; GDY2-2007; GDYF1; GS2008; GXHZ12; GXHZ13; GXHZ14; GXHZ16; GXHZ19; GXHZ2; GXHZ21; GXHZ4; GXLZ5; GXLZ7; GY; GZCJ; GZDJ; GZHW1; GZHW2; GZHX; GZJS; GZKB; GZKY; GZLJ1; GZWB; GZWM; GZZB; Hainan-1; Hainan-2; HB1; HB2; НВ3; НВ-Tsh1; HB-Xt1; HEN46; HeN-KF; HeN-LH; HeN-LY; HLJDF; HLJMZ1; HLJMZ2; HLJMZ3; HLJZY; HM-1; HN2; HN2007; HN3; HN1d; HNly; HNLY01; HNNX01; HNPJ01; HNsp; HNXT1; HNyy; HNyz; HQ-5; HQ-6; HUB; HuN; HUN1; HUN11; HUN15; HUN16; HUN17; HUN2; HUN3; HUN4; HUN5; HUN6; HUN7; Hunan-1; Hunan-2; Hunan-3; HUNH2; HUNH4; HuNh1; HUNL1; HUNX4; HZ061226; HZ070105; Jiangsu-1; Jiangsu-2; Jiangsu-3; Jiangxi-2; Jiangxi-4; JLYS; JN; JX1; JX143; JX2; JX-2; JX2006; JX3; JX4; JX5; JXA1; KS06; LC07; LJ; LS06; LS-4; LY07; NB070319; SC07; SD; SD14; SDWF2; SH02; ST-7; SX2007; SY0608; TJDMJ; TJZHJ2; TJZHJ3; TQ; TQ07; TW07; WF07; XJ07; XL2008; YN2008; YNBS; YNDL; YNMG; YNWS; YNYS; YNYX1; YNYX3; ZJ06; ZJCJ; ZJWL; ZX07 и ZS070921. ! 8. Способ по пп.1-7, в котором композиция содержит также адъювант. ! 9. Спосо
Claims (15)
1. Способ вакцинации свиньи от воздействия отличающейся высокой температурой формы PRRS, заключающийся в том, что вводят свинье иммуногенную композицию, содержащую в эффективном количестве вирус PRRS типа II.
2. Способ по п.1, в котором отличающаяся высокой температурой форма PRRS вызывается китайским штаммом PRRSV, который имеет нуклеотидную последовательность, гомологичную по меньшей мере на 95% нуклеотидной последовательности штамма НВ-1 или JX143.
3. Способ по п.1, в котором отличающаяся высокой температурой форма PRRS вызывается вирусом HP PRRS.
4. Способ по п.1, в котором вирус PRRS типа II является ослабленным.
5. Способ по п.3, отличающийся тем, что вирус PRRS типа II представляет собой ослабленную форму штамма, который имеет регистрационный № АТСС VR-2332, или его потомство.
6. Способ по п.4, отличающийся тем, что вирус PRRS типа II представляет собой штамм, который имеет регистрационный №АТСС VR-2495, или его потомство.
7. Способ по п.1, в котором китайский штамм PRRSV выбирают из группы, включающей АН-1; AHCFSH; AHCFZC; BB07; BD-8; BQ07; CL07; СХ07; CZ07; FY060915; FY080108; GC-2; GCH-3; GDI; GD2; GD2007; GD3; GD4; GDSD1; GDY1-2007; GDY2-2007; GDYF1; GS2008; GXHZ12; GXHZ13; GXHZ14; GXHZ16; GXHZ19; GXHZ2; GXHZ21; GXHZ4; GXLZ5; GXLZ7; GY; GZCJ; GZDJ; GZHW1; GZHW2; GZHX; GZJS; GZKB; GZKY; GZLJ1; GZWB; GZWM; GZZB; Hainan-1; Hainan-2; HB1; HB2; НВ3; НВ-Tsh1; HB-Xt1; HEN46; HeN-KF; HeN-LH; HeN-LY; HLJDF; HLJMZ1; HLJMZ2; HLJMZ3; HLJZY; HM-1; HN2; HN2007; HN3; HN1d; HNly; HNLY01; HNNX01; HNPJ01; HNsp; HNXT1; HNyy; HNyz; HQ-5; HQ-6; HUB; HuN; HUN1; HUN11; HUN15; HUN16; HUN17; HUN2; HUN3; HUN4; HUN5; HUN6; HUN7; Hunan-1; Hunan-2; Hunan-3; HUNH2; HUNH4; HuNh1; HUNL1; HUNX4; HZ061226; HZ070105; Jiangsu-1; Jiangsu-2; Jiangsu-3; Jiangxi-2; Jiangxi-4; JLYS; JN; JX1; JX143; JX2; JX-2; JX2006; JX3; JX4; JX5; JXA1; KS06; LC07; LJ; LS06; LS-4; LY07; NB070319; SC07; SD; SD14; SDWF2; SH02; ST-7; SX2007; SY0608; TJDMJ; TJZHJ2; TJZHJ3; TQ; TQ07; TW07; WF07; XJ07; XL2008; YN2008; YNBS; YNDL; YNMG; YNWS; YNYS; YNYX1; YNYX3; ZJ06; ZJCJ; ZJWL; ZX07 и ZS070921.
8. Способ по пп.1-7, в котором композиция содержит также адъювант.
9. Способ вакцинации свиньи от воздействия вируса JX143, который вызывает отличающуюся высокой температурой форму PRRS, заключающийся в том, что вводят свинье иммуногенную композицию, содержащую в эффективном количестве вирус PRRS типа II.
10. Способ снижения коэффициента заболеваемости или серьезности клинических симптомов отличающихся высокой температурой форм заболевания PRRS, заключающийся в том, что вводят свинье, которая нуждается в этом, иммуногенную композицию, содержащую в эффективном количестве вирус PRRS типа II.
11. Способ снижения коэффициента заболеваемости или серьезности клинических симптомов отличающихся высокой температурой форм заболевания PRRS, заключающийся в том, что вводят свинье, которая нуждается в этом, иммуногенную композицию, содержащую в эффективном количестве вирус PRRS типа II, в котором отличающаяся высокой температурой форма заболевания PRRS вызывается китайским штаммом PRRSV, который имеет нуклеотидную последовательность, гомологичную по меньшей мере на 95% нуклеотидной последовательности штамма НВ-1 или JX143.
12. Применение вируса PRRS типа II для вакцинации свиньи от воздействия отличающейся высокой температурой формы PRRS, заключающийся в том, что вводят свинье, которая нуждается в этом, иммуногенную композицию, содержащую в эффективном количестве вирус PRRS типа II.
13. Применение по п.12, в котором отличающаяся высокой температурой форма заболевания PRRS вызывается китайским штаммом PRRSV, который имеет нуклеотидную последовательность, гомологичную по меньшей мере на 95% нуклеотидной последовательности штамма НВ-1 или JX143.
14. Применение вируса PRRS типа II для приготовления фармацевтической композиции, предназначенной для вакцинации свиньи от воздействия отличающейся высокой температурой формы PRRS, заключающийся в том, что вводят свинье иммуногенную композицию, содержащую в эффективном количестве вирус PRRS типа II.
15. Применение по п.14, в котором отличающаяся высокой температурой форма заболевания PRRS вызывается китайским штаммом PRRSV, который имеет нуклеотидную последовательность, гомологичную по меньшей мере на 95% нуклеотидной последовательности штамма НВ-1 или JX143.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9161408P | 2008-08-25 | 2008-08-25 | |
US61/091,614 | 2008-08-25 | ||
PCT/US2009/054775 WO2010025109A1 (en) | 2008-08-25 | 2009-08-24 | Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs) |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011110910A true RU2011110910A (ru) | 2012-09-27 |
RU2561595C2 RU2561595C2 (ru) | 2015-08-27 |
Family
ID=41721850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011110910/15A RU2561595C2 (ru) | 2008-08-25 | 2009-08-24 | Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs) |
Country Status (13)
Country | Link |
---|---|
US (1) | US20110117129A1 (ru) |
EP (1) | EP2328612A4 (ru) |
JP (2) | JP5619004B2 (ru) |
KR (1) | KR101653177B1 (ru) |
CN (2) | CN102316895A (ru) |
AU (1) | AU2009285843B2 (ru) |
BR (1) | BRPI0917887A2 (ru) |
CA (1) | CA2734390A1 (ru) |
CL (1) | CL2011000382A1 (ru) |
MX (1) | MX2011002046A (ru) |
RU (1) | RU2561595C2 (ru) |
UA (1) | UA106475C2 (ru) |
WO (1) | WO2010025109A1 (ru) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
JP3961222B2 (ja) | 1999-03-08 | 2007-08-22 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Prrsvワクチン |
DK1183332T3 (da) | 1999-04-22 | 2010-09-06 | Us Agriculture | Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142 |
KR20070028547A (ko) | 2004-06-18 | 2007-03-12 | 리전츠 오브 더 유니버스티 오브 미네소타 | 바이러스에 감염되고 백신접종된 생물의 동정 |
US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
CA2611820C (en) | 2005-06-24 | 2015-10-06 | Regents Of The University Of Minnesota | Prrs viruses, infectious clones, mutants thereof, and methods of use |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
SG192821A1 (en) | 2011-02-17 | 2013-09-30 | Boehringer Ingelheim Vetmed | Commercial scale process for production of prrsv |
WO2012110489A2 (en) | 2011-02-17 | 2012-08-23 | Boehringer Ingelheim Vetmedica Gmbh | Novel european prrsv strain |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
US9315781B2 (en) | 2011-07-29 | 2016-04-19 | Boehringer Ingelheim Vetmedica Gmbh | Infectious CDNA clone of european PRRS virus and uses thereof |
EP2739312B1 (en) * | 2011-08-03 | 2017-10-04 | Children's Medical Center Corporation | A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
CN102716482B (zh) * | 2012-03-07 | 2014-01-01 | 齐鲁动物保健品有限公司 | 一种高致病性猪繁殖与呼吸综合征活疫苗稀释液 |
KR101430223B1 (ko) * | 2012-10-09 | 2014-09-25 | 전북대학교산학협력단 | 면역유도능이 증가된 돼지생식기호흡기증후군 바이러스 |
US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
KR101502360B1 (ko) * | 2013-03-20 | 2015-03-25 | 주식회사 옵티팜 | 신규한 국내형 돼지생식기호흡기증후군 바이러스 |
ES2695172T3 (es) * | 2013-12-03 | 2019-01-02 | Intervet Int Bv | Vacuna porcina contra SRRP y Lawsonia intracellularis |
CA2930042C (en) | 2013-12-20 | 2022-06-21 | Boehringer Ingelheim Vetmedica Gmbh | Prrs virus variant, european prrs virus cdna clone, and uses thereof |
CN106237324B (zh) * | 2016-08-30 | 2020-07-24 | 齐鲁动物保健品有限公司 | 一种使用全悬浮技术生产猪传染性胃肠炎疫苗的方法 |
JP7129978B2 (ja) * | 2016-12-14 | 2022-09-02 | ゾエティス・サービシーズ・エルエルシー | 豚繁殖・呼吸障害症候群(prrs)ウイルスの欧州株に対抗する離乳前の効果的なワクチン接種 |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3137631A (en) * | 1959-12-01 | 1964-06-16 | Faberge Inc | Encapsulation in natural products |
US3080291A (en) * | 1960-06-10 | 1963-03-05 | Jensen Salsberg Lab Inc | Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom |
US3959457A (en) * | 1970-06-05 | 1976-05-25 | Temple University | Microparticulate material and method of making such material |
US4015100A (en) * | 1974-01-07 | 1977-03-29 | Avco Everett Research Laboratory, Inc. | Surface modification |
US4122167A (en) * | 1977-02-09 | 1978-10-24 | Merck & Co., Inc. | Respiratory synctial vaccine |
US4205060A (en) * | 1978-12-20 | 1980-05-27 | Pennwalt Corporation | Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use |
US4224412A (en) * | 1979-05-01 | 1980-09-23 | Dorofeev Viktor M | Living virus culture vaccine against canine distemper and method of preparing same |
US4554159A (en) * | 1981-11-12 | 1985-11-19 | Institute Merieux | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) |
US4452747A (en) * | 1982-03-22 | 1984-06-05 | Klaus Gersonde | Method of and arrangement for producing lipid vesicles |
US4468346A (en) * | 1983-10-27 | 1984-08-28 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies to porcine immunoglobulins |
DE3405100A1 (de) * | 1984-02-14 | 1985-08-14 | Drägerwerk AG, 2400 Lübeck | Pt-katalysator auf einem traeger als luftreinigungsmittel |
US4744933A (en) * | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
US5008050A (en) * | 1984-06-20 | 1991-04-16 | The Liposome Company, Inc. | Extrusion technique for producing unilamellar vesicles |
US4921706A (en) * | 1984-11-20 | 1990-05-01 | Massachusetts Institute Of Technology | Unilamellar lipid vesicles and method for their formation |
US4606940A (en) * | 1984-12-21 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation and encapsulation |
US5206163A (en) * | 1985-07-08 | 1993-04-27 | Chiron Corporation | DNA encoding bovine diarrhea virus protein |
US4753884A (en) * | 1986-01-28 | 1988-06-28 | Novagene, Inc. | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
FR2602791B1 (fr) * | 1986-08-18 | 1988-11-10 | Ministere Agri Direction Quali | Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu |
US5009956A (en) * | 1987-02-24 | 1991-04-23 | Univ Minnesota | Phospholipase A2-resistant liposomes |
US5213759A (en) * | 1988-05-05 | 1993-05-25 | Elopak Systems A.G. | Sterilization |
US4927637A (en) * | 1989-01-17 | 1990-05-22 | Liposome Technology, Inc. | Liposome extrusion method |
US4944948A (en) * | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
US5132117A (en) * | 1990-01-11 | 1992-07-21 | Temple University | Aqueous core microcapsules and method for their preparation |
ATE118352T1 (de) * | 1991-06-06 | 1995-03-15 | Stichting Centr Diergeneeskund | Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits. |
MX9204885A (es) * | 1991-08-26 | 1994-05-31 | Boehringer Animal Health Inc | Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos. |
US6042830A (en) * | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
US6080570A (en) * | 1991-08-26 | 2000-06-27 | Boehringer Ingelheim Vetmedica, Inc. | Method of producing a vaccine for Swine Infertility and Respiratory Syndrome |
ATE144144T1 (de) * | 1991-08-26 | 1996-11-15 | James Edward Collins | Vakzine gegen und diagnosemethode für das schweine-unfruchtbarkeits- und atmungs-syndrom (suas) |
US6982160B2 (en) * | 1991-08-26 | 2006-01-03 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions that include SIRS virus |
US5846805A (en) * | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
FR2686097B1 (fr) * | 1992-01-14 | 1994-12-30 | Rhone Merieux | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
US5338543A (en) * | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
TW289731B (ru) * | 1992-07-09 | 1996-11-01 | Akzo Nv | |
US6773908B1 (en) * | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6592873B1 (en) * | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6251397B1 (en) * | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
US6380376B1 (en) * | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US5419907A (en) * | 1992-11-10 | 1995-05-30 | Iowa State University Research Foundation, Inc. | Pathogenic porcine respiratory coronavirus |
EP0683816B1 (en) * | 1993-02-08 | 2000-11-02 | Bayer Corporation | Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
EP0659885A1 (en) * | 1993-12-21 | 1995-06-28 | Akzo Nobel N.V. | Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
DE4407489A1 (de) * | 1994-03-07 | 1995-09-14 | Bayer Ag | Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines |
EP0676467B1 (en) * | 1994-04-11 | 2001-10-04 | Akzo Nobel N.V. | European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV) |
GB2289279B (en) * | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
ATE329616T1 (de) * | 1994-08-05 | 2006-07-15 | Univ Minnesota | Virale nukleotidsequenz vr-2332 und nutzungsverfahren |
EP0732340B1 (en) * | 1995-03-14 | 2004-06-09 | Akzo Nobel N.V. | Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
US5690940A (en) * | 1995-06-21 | 1997-11-25 | Regents Of The University Of Minnesota | Low pathogencity PRRS live virus vaccines and methods of preparation thereof |
ES2102971B1 (es) * | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
US5866401A (en) * | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
US6015663A (en) * | 1996-03-01 | 2000-01-18 | The United States Of America As Represented By The Secretary Of Agriculture | Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains |
US5976537A (en) * | 1996-07-02 | 1999-11-02 | The United States Of America As Represented By The Secretary Of Agriculture | Porcine reproductive and respiratory syndrome vaccine |
ATE199022T1 (de) * | 1996-10-09 | 2001-02-15 | Akzo Nobel Nv | Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des sweins (prrsv) |
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
CN1259141B (zh) * | 1997-05-06 | 2013-03-27 | 勃林格殷格汉动物保健有限公司 | 用于疫苗或诊断测试中的鉴定prrs病毒的肽序列的prrsv抗原位点 |
US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
US7211379B2 (en) * | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
NZ513289A (en) * | 1998-12-22 | 2003-04-29 | Pfizer Prod Inc | Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7132106B2 (en) * | 1998-12-22 | 2006-11-07 | Pfizer Inc. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
FR2789695B1 (fr) * | 1999-02-11 | 2003-03-07 | Merial Sas | Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs |
JP3961222B2 (ja) * | 1999-03-08 | 2007-08-22 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Prrsvワクチン |
DK1183332T3 (da) * | 1999-04-22 | 2010-09-06 | Us Agriculture | Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142 |
US20040213805A1 (en) * | 1999-10-12 | 2004-10-28 | Verheije Monique Helene | Deletions in arterivirus replicons |
US20020012670A1 (en) * | 2000-01-26 | 2002-01-31 | Knut Elbers | Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV) |
EP1156111A1 (en) * | 2000-05-19 | 2001-11-21 | Stichting Dienst Landbouwkundig Onderzoek | Chimeric arterivirus-like particles |
US7018638B2 (en) * | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US6841364B2 (en) * | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
EP1350840B1 (en) * | 2002-04-05 | 2012-05-09 | Boehringer Ingelheim Vetmedica GmbH | Adaptation sites of PRRSV |
US20060063151A1 (en) * | 2004-09-21 | 2006-03-23 | Michael Roof | Porcine reproductive and respiratory syndrome isolates and methods of use |
EP1838343B1 (en) * | 2005-01-13 | 2010-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Prrs vaccines |
CN101205539B (zh) * | 2007-12-14 | 2010-11-24 | 中国农业科学院上海兽医研究所 | 高致病性猪蓝耳病病毒重组质粒和遗传工程疫苗 |
-
2009
- 2009-08-24 CN CN2009801333254A patent/CN102316895A/zh active Pending
- 2009-08-24 RU RU2011110910/15A patent/RU2561595C2/ru active
- 2009-08-24 EP EP09810488A patent/EP2328612A4/en not_active Withdrawn
- 2009-08-24 BR BRPI0917887A patent/BRPI0917887A2/pt not_active IP Right Cessation
- 2009-08-24 WO PCT/US2009/054775 patent/WO2010025109A1/en active Application Filing
- 2009-08-24 AU AU2009285843A patent/AU2009285843B2/en not_active Withdrawn - After Issue
- 2009-08-24 US US13/055,590 patent/US20110117129A1/en not_active Abandoned
- 2009-08-24 UA UAA201103422A patent/UA106475C2/ru unknown
- 2009-08-24 MX MX2011002046A patent/MX2011002046A/es not_active Application Discontinuation
- 2009-08-24 CN CN201611130224.XA patent/CN108704127A/zh active Pending
- 2009-08-24 KR KR1020117004020A patent/KR101653177B1/ko active IP Right Grant
- 2009-08-24 CA CA2734390A patent/CA2734390A1/en not_active Abandoned
- 2009-08-24 JP JP2011525125A patent/JP5619004B2/ja active Active
-
2011
- 2011-02-22 CL CL2011000382A patent/CL2011000382A1/es unknown
-
2014
- 2014-06-03 JP JP2014114697A patent/JP5890469B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CA2734390A1 (en) | 2010-03-04 |
MX2011002046A (es) | 2011-04-21 |
CN102316895A (zh) | 2012-01-11 |
CL2011000382A1 (es) | 2012-02-17 |
EP2328612A1 (en) | 2011-06-08 |
UA106475C2 (ru) | 2014-09-10 |
AU2009285843A1 (en) | 2010-03-04 |
JP2012500852A (ja) | 2012-01-12 |
BRPI0917887A2 (pt) | 2019-09-03 |
AU2009285843B2 (en) | 2014-07-17 |
WO2010025109A1 (en) | 2010-03-04 |
WO2010025109A8 (en) | 2011-06-03 |
JP5619004B2 (ja) | 2014-11-05 |
CN108704127A (zh) | 2018-10-26 |
KR101653177B1 (ko) | 2016-09-01 |
KR20110068980A (ko) | 2011-06-22 |
US20110117129A1 (en) | 2011-05-19 |
JP2014193902A (ja) | 2014-10-09 |
RU2561595C2 (ru) | 2015-08-27 |
EP2328612A4 (en) | 2012-11-14 |
JP5890469B2 (ja) | 2016-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011110910A (ru) | Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs) | |
Jiang et al. | DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity | |
Jiang et al. | Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus | |
Costers et al. | GP4 of porcine reproductive and respiratory syndrome virus contains a neutralizing epitope that is susceptible to immunoselection in vitro | |
JP4750125B2 (ja) | ブタ繁殖・呼吸障害症候群ウイルス株及び組成物 | |
JP4320357B2 (ja) | ブタ生殖器呼吸器症候群ウイルスのnタンパク質変異体 | |
Zheng et al. | Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV) | |
CA2859944A1 (en) | Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs) | |
WO1998000165A1 (en) | Porcine reproductive and respiratory syndrome vaccine | |
EP2931741B1 (en) | Porcine parvovirus 5a, methods of use and vaccine | |
Nam et al. | Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus | |
Lee et al. | Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5 | |
Li et al. | Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4 | |
Sun et al. | Attempts to enhance cross-protection against porcine reproductive and respiratory syndrome viruses using chimeric viruses containing structural genes from two antigenically distinct strains | |
Ren et al. | Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virus | |
Dong et al. | Immune responses of mice immunized by DNA plasmids encoding PCV2 ORF 2 gene, porcine IL-15 or the both | |
Jeong et al. | Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus | |
Chen et al. | A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challenge | |
Tang et al. | Positive effects of porcine IL-2 and IL-4 on virus-specific immune responses induced by the porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 DNA vaccine in swine | |
Misinzo et al. | Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge | |
JP5306943B2 (ja) | 弱毒ウイルスの作出方法 | |
WO1998046263A1 (en) | Saponin adjuvants in combination with dna vaccination | |
Savard et al. | FosteraTM PRRS modified live vaccine efficacy against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus (PRRSV) | |
Misinzo et al. | EFFICACY OF AN INACTIVATED PRRSV VACCINE | |
PL236776B1 (pl) | Wyizolowany szczep bakterii Mycoplasma bovis i szczepionka zawierająca szczep bakterii Mycoplasma bovis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC43 | Official registration of the transfer of the exclusive right without contract for inventions |
Effective date: 20191108 |